Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial

NCT02235064 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT02235064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02235064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial
Lead sponsor
The Cooper Health System
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2014
Completion date
July 31, 2015
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, postpartum